Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease
Information
- DOI:
- https://doi.org/10.1002/14651858.CD005055.pub2Copy DOI
- Database:
-
- Cochrane Database of Systematic Reviews
- Version published:
-
- 19 October 2005see what's new
- Type:
-
- Intervention
- Stage:
-
- Review
- Cochrane Editorial Group:
-
Cochrane Anaesthesia Group
- Copyright:
-
- Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Article metrics
Altmetric:
Cited by:
Authors
Contributions of authors
Conceiving the review: Dr Matthew J. Bizzarro (MB)
Co‐ordinating the review: (MB)
Undertaking manual searches: (MB)
Screening search results:(MB) and Dr Ian Gross (IG)
Organizing retrieval of papers: (MB)
Screening retrieved papers against inclusion criteria: D (MB)
Appraising quality of papers: (MB and IG)
Abstracting data from papers: (MB)
Writing to authors of papers for additional information: (MB)
Providing additional data about papers: (MB)
Obtaining and screening data on unpublished studies: (MB)
Data management for the review: (MB)
Entering data into Review Manager (RevMan 4.2): (MB)
RevMan statistical data: (MB)
Other statistical analysis not using RevMan:(MB)
Double entry of data: (MB and IG)
Interpretation of data: (MB and IG)
Statistical inferences: (MB)
Writing the review: (MB)
Securing funding for the review: N/A
Performing previous work that was the foundation of the present study: (MB)
Guarantor for the review (one author): (MB)
Person responsible for reading and checking review before submission: (MB and IG)
Sources of support
Internal sources
-
Yale University School of Medicine, USA.
External sources
-
No sources of support supplied
Declarations of interest
None known
Acknowledgements
We would like to thank Dr Mathew Zacharias, Prof. Marcus Müllner, Dr Tom Pedersen, Dr Karen Burns, Dr Keith Barrington, and The Cochrane Heart Group peer reviewers and consumer panel for their help and editorial advice during the preparation of our protocol. We would also like to thank Dr Mathew Zacharias, Dr Keith Barrington, Dr Ronald Day, Dr Robert Tulloh, Prof Nathan Pace, Kathie Godfrey, Janet Wale, and Jane Cracknell for their assistance and editorial comments during the preparation of this review.
We would like to thank Dr Ronald Day for the contribution of his individual patient data for analysis and inclusion in this review.
We would also like to thank Dr Michael Bracken for his instruction in the concepts and principles of evidence‐based medicine and the preparation of a systematic review in addition to his statistical assistance with the analyses of data.
Version history
| Published | Title | Stage | Authors | Version |
| 2014 Jul 03 | Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease | Review | Matthew Bizzarro, Ian Gross, Fabiano T Barbosa | |
| 2005 Oct 19 | Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease | Review | Matthew Bizzarro, Ian Gross | |
| 2004 Apr 19 | Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease | Protocol | Matthew Bizzarro, Ian Gross | |
Differences between protocol and review
No data were available for some of the outcomes desired for analysis, including long‐term mortality, length of hospital stay, and incidence and severity of neurodevelopmental disability.
Notes
None
